Healthcare provider profile · identity verified

Madhu V Gupta

Family Practice · DEARBORN, MI · NPI 1770528705

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	552	47
Alprazolam	Alprazolam	373	36
Atorvastatin Calcium	Atorvastatin Calcium	256	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	246	23
Gabapentin	Gabapentin	222	28
Promethazine Hcl	Promethazine Hcl	193	24
Albuterol Sulfate Hfa	Albuterol Sulfate	191	32
Morphine Sulfate Er	Morphine Sulfate	180	17
Omeprazole	Omeprazole	169	27
Famotidine	Famotidine	160	16
Amlodipine Besylate	Amlodipine Besylate	146	20
Ibuprofen	Ibuprofen	144	20
Levothyroxine Sodium	Levothyroxine Sodium	116	18
Fluticasone Propionate	Fluticasone Propionate	115	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	105	14
Montelukast Sodium	Montelukast Sodium	104	15
Diazepam	Diazepam	98	suppressed
Potassium Chloride	Potassium Chloride	97	11
Albendazole	Albendazole	94	suppressed
Furosemide	Furosemide	90	13
Lisinopril	Lisinopril	87	17
Metformin Hcl	Metformin Hcl	87	19
Aripiprazole Odt	Aripiprazole	83	suppressed
Tramadol Hcl	Tramadol Hcl	80	11
Metoprolol Succinate	Metoprolol Succinate	78	11
Desipramine Hcl	Desipramine Hcl	77	suppressed
Losartan Potassium	Losartan Potassium	77	15
Bupropion Hcl Sr	Bupropion Hcl	73	11
Fluoxetine Hcl	Fluoxetine Hcl	70	11
Sertraline Hcl	Sertraline Hcl	66	15
Diflorasone Diacetate	Diflorasone Diacetate	64	13
Metoprolol Tartrate	Metoprolol Tartrate	63	11
Lubiprostone	Lubiprostone	62	12
Venlafaxine Hcl Er	Venlafaxine Hcl	61	suppressed
Duloxetine Hcl	Duloxetine Hcl	60	11
Mirtazapine	Mirtazapine	59	suppressed
Halobetasol Propionate	Halobetasol Propionate	57	suppressed
Fluconazole	Fluconazole	55	15
Tamsulosin Hcl	Tamsulosin Hcl	54	suppressed
Diclofenac Sodium	Diclofenac Sodium	51	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Ondansetron Odt	Ondansetron	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Doxepin Hcl	Doxepin Hcl	42	suppressed
Trazodone Hcl	Trazodone Hcl	41	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Lovastatin	Lovastatin	40	suppressed
Atenolol	Atenolol	39	suppressed
Nitroglycerin	Nitroglycerin	38	suppressed
Topiramate	Topiramate	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Methocarbamol	Methocarbamol	36	suppressed
Azithromycin	Azithromycin	35	14
Oxycontin	Oxycodone Hcl	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Carvedilol	Carvedilol	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Simvastatin	Simvastatin	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Methylprednisolone	Methylprednisolone	30	17
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	suppressed
Naloxone Hcl	Naloxone Hcl	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Lithium Carbonate	Lithium Carbonate	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Glipizide	Glipizide	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Primidone	Primidone	26	suppressed
Betamethasone Valerate	Betamethasone Valerate	25	suppressed
Naproxen	Naproxen	25	suppressed
Eliquis	Apixaban	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Amoxicillin	Amoxicillin	22	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	22	suppressed
Estradiol	Estradiol	22	suppressed
Albuterol Sulfate	Albuterol Sulfate	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	20	17
Quetiapine Fumarate Er	Quetiapine Fumarate	20	suppressed
Megestrol Acetate	Megestrol Acetate	19	suppressed
Prednisone	Prednisone	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Ozempic	Semaglutide	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Proair Respiclick	Albuterol Sulfate	13	suppressed
Sumatriptan	Sumatriptan	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Moxifloxacin	Moxifloxacin Hcl	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Selenium Sulfide	Selenium Sulfide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error